Hypertension Journal

JANUARY 2, 2024

Hypertension is the primary modifiable risk factor for cardiovascular, renal, and cerebrovascular diseases and is considered the main contributing factor to morbidity and mortality worldwide. Hypertension, Ahead of Print.

Hypertension 40

Hypertension Blood Pressure Cerebrovascular Disease Risk Factors 40

Stroke Journal

JANUARY 30, 2025

Objective:Socioeconomic disparities significantly affect the treatment and outcomes of cardiovascular and cerebrovascular diseases, including acute ischemic stroke. Further research is needed to confirm. Stroke, Volume 56, Issue Suppl_1 , Page AWP158-AWP158, February 1, 2025.

Outcomes 40

Outcomes Stroke Strokes Hospital 40

Stroke Journal

OCTOBER 10, 2023

BACKGROUND:Patients with end-stage kidney disease undergoing dialysis are at significant risk of stroke. Whether dialysis modality is associated with cerebrovascular disease is unclear. Stroke, Volume 54, Issue 12 , Page 3054-3063, December 1, 2023. women) and 11 427 patients undergoing hemodialysis (mean age 59±13 years; 47.3%

Kidney Disease 40

Kidney Disease Stroke Strokes Cerebrovascular Disease 40

Frontiers in Cardiovascular Medicine

FEBRUARY 10, 2025

Current smoker, hypertension, heart failure, previous myocardial infarction, cerebrovascular disease, CysC, and NT-proBNP were selected as independent risk factors for AKI. The risk prediction model was evaluated using receiver operating characteristic (ROC), calibration curve, and decision curve analysis (DCA).Results220

Heart Valves 40

Heart Valves Risk Factors Cerebrovascular Disease Myocardial Infarction 40

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

However, there have been few studies which detail such a rapid progression of microhemorrhages in this patient population as well as such a late progression of the disease. Our case demonstrates a unique presentation of CADASIL and provides a remarkable example of rapid, late‐in‐life disease presentation.

Arterioles 40

Arterioles Cerebrovascular Disease Outpatient Document 40

DAIC

JANUARY 23, 2024

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 1,2 ASCVD causes or contributes to conditions that include coronary artery disease (CAD), cerebrovascular disease, and peripheral vascular disease (inclusive of aortic aneurysm).3

Cardiovascular Disease 111

Cardiovascular Disease Heart Attack Heart attacks Coronary Artery Disease 111

Cardiomatics

AUGUST 4, 2022

According to WHO , cardiovascular diseases are the leading cause of death worldwide – it is estimated that they are the cause of 17.9 Cardiovascular diseases are a group of diseases of the heart and blood vessels. They include coronary artery disease, cerebrovascular disease, and rheumatic heart disease.

Cardiovascular Disease 52

Cardiovascular Disease Technology COVID-19 Coronary Artery Disease 52

Stroke Journal

JANUARY 30, 2025

This study used deidentified, publicly available data and was deemed not human research by the University of Nevada, Reno IRB.Results:From 1999 to 2020, the overall U.S. AAMR for cerebrovascular disease declined, with an average annual percent change (AAPC) of -2.03% (95% CI: -2.34 with p < 0.05 indicating significance.

Cerebrovascular Disease 40

Cerebrovascular Disease Public Health Certification Document 40

Stroke Journal

JANUARY 30, 2025

This study used deidentified, publicly available data and was deemed not human research by the University of Nevada, Reno IRB.Results:From 1999 to 2020, the overall U.S. AAMR for cerebrovascular disease declined, with an average annual percent change (AAPC) of -2.03% (95% CI: -2.34 with p < 0.05 indicating significance.

Cerebrovascular Disease 40

Cerebrovascular Disease Public Health Certification Document 40

Stroke Journal

JANUARY 30, 2025

Introduction:In mid- to high-latitude regions, cerebrovascular diseases (CBVD) are known to peak during the winter. Seasonality and climate factors can be considered predisposing risk factors for cerebrovascular disease. Stroke, Volume 56, Issue Suppl_1 , Page AWP313-AWP313, February 1, 2025.

Cerebrovascular Disease 40

Cerebrovascular Disease Risk Factors Document Obesity 40

DAIC

FEBRUARY 7, 2024

During the American Stroke Association’s International Stroke Conference 2024, ISC24, eleven scientists leading the way in stroke research will be recognized for their exceptional professional achievements. The world premier meeting for researchers and clinicians dedicated to the science of stroke and brain health is being held Feb.

Stroke 105

Stroke Strokes Research Health Disparities 105

DAIC

JANUARY 22, 2024

Image courtesy: ASA/AHA christine.book Mon, 01/22/2024 - 18:03 January 23, 2024 — Focused on delivering the latest scientific advancements and new treatments in cerebrovascular diseases and brain health science from around the world, this year's International Stroke Conference, ISC 2024 , will be held Feb. 7-9 in Phoenix, Arizona.

Stroke 100

Stroke Strokes Hospital Stents 100

Stroke Journal

FEBRUARY 1, 2024

However, the role of these genetic risk variants in the development of cerebrovascular disease in Native Hawaiians remains unknown. Background:Diabetes is a highly heritable stroke risk factor with numerous known genetic risk variants. Genetic predisposition to diabetes was associated with a 23% higher risk of diabetes (OR 1.23, CI 1.01-1.51;

Genetic predisposition 40

Genetic predisposition Diabetes Stroke Strokes 40

Dr. Smith's ECG Blog

APRIL 8, 2015

Positive predictors of 7-day cardiac outcomes included age greater than 60 years , male gender, congestive heart failure , ischemic heart disease , cardiac arrhythmia , and valvular heart disease. Negative predictors included dementia, pacemaker, coronary revascularization, and cerebrovascular disease. 16) Linzer M.

Arrhythmia 52

Arrhythmia Outcomes Risk Factors Chest Pain 52

Frontiers in Cardiovascular Medicine

JANUARY 8, 2025

ObjectiveThis meta-analysis aims to evaluate the safety and efficacy of indobufen in the treatment of cardiovascular diseases, cerebrovascular diseases, and thromboembolic disorders. The primary focus is on the incidence of major adverse cardiovascular events (MACE), thrombosis, bleeding events, and adverse reactions.

Cerebrovascular Disease 52

Cerebrovascular Disease Cardiovascular Disease Myocardial Infarction Angina 52

Frontiers in Cardiovascular Medicine

NOVEMBER 25, 2024

Cardiovascular diseases (CVDs) encompass a range of disorders affecting the heart and blood vessels, such as coronary heart disease, cerebrovascular disease (e.g., stroke), peripheral arterial disease, congenital heart anomalies, deep vein thrombosis, and pulmonary embolism.

Cardiovascular Disease 59

Cardiovascular Disease Peripheral Arterial Disease Cerebrovascular Disease Thrombosis 59

Frontiers in Cardiovascular Medicine

JANUARY 6, 2025

Elevated cardiovascular mortality risks were observed across all subgroups, including diseases of the heart (IRR 1.79, 95% CI 1.751.82), cerebrovascular diseases (IRR 1.52, 95% CI 1.451.59), and other cardiovascular diseases (IRR 1.78, 95% CI 1.671.90).

Cancer 52

Cancer Cerebrovascular Disease Quality of Life Cardiovascular Disease 52

Frontiers in Cardiovascular Medicine

MARCH 3, 2025

ObjectiveUric acid (UA), fibrinogen (FIB), and homocysteine (Hcy) are the main contributors to cardiovascular and cerebrovascular diseases, and are related to hypertension. Hypertension plays a role in atherosclerosis (CAS).

Atherosclerosis 52

Atherosclerosis Hypertension Plaque Cerebrovascular Disease 52